590. Can $55 Billion End the Opioid Epid...

<p>A Trump executive order is giving retail investors more access to private markets. Is that a golden opportunity — or fool’s gold?</p><p> </p><ul><li><strong>SOURCES:</strong><ul><li><a href="https://law.duke.edu/fac/defontenay/">Elisabeth de Fontenay,</a> professor of law at D ... Show More

<p>Thoroughbred auction prices keep setting records. But tracks are closing, gambling revenues are falling, and the sport is increasingly reliant on subsidies. Is that the kind of long shot anybody wants? (Part three of a series, “<a href="https://freakonomics.com/the-horse-is-us ... Show More

<p>The world has changed a good bit since <i>Freakonomics</i> was first published. In this live anniversary episode, Stephen Dubner tells Geoff Bennett of <i>PBS NewsHour </i>everything he has learned since then. Happy birthday, <i>Freakonomics.</i></p><p> </p><ul><li><strong>SOU ... Show More

Mark Parrino has been involved with the delivery of health care and treatment for opioid use disorder (OUD) since 1974. As the president of the American Association for the Treatment of Opioid Dependence, Inc. (AATOD), he works with treatment providers across the country to devel ... Show More

In the U.S. doctors often prescribe opioids for pain management, and it's no secret that these substances are a big business for pharmaceutical companies -- and, increasingly, it's no secret that exposure to these legal pills are turning patients into unwilling addicts. So how ex ... Show More

<p align="center"><em>"We should never, ever forget that addiction treatment is a search for meaning in a place other than using drugs."</em></p> <p align="center"><em>—Nancy Campbell, historian of drug addiction</em></p> <p>(This is the third and final chapter of a three-part se ... Show More

This episode is brought to you by Cozy Earth, InisdeTracker, and Rupa Health. If you or a loved one struggle with addiction, this is an episode you’re going to want to listen to. Many of our current pharmaceuticals stem from compounds discovered in plant medicines. And many benef ... Show More

The Supreme Court recently blocked a bankruptcy deal that would have given full immunity to the members of the Sackler family who once controlled Purdue Pharma, the maker of OxyContin. Trevor Noah calls out the frustrating contradictions within the initial deal and shares his tho ... Show More